LncRNA Polymorphisms and Lung Cancer Risk

References

• Chen W , ZhengR , BaadePDet al. Cancer statistics in China, 2015. CA Cancer J. Clin.66(2), 115–132 (2016).
   PubMed Web of Science ®Google Scholar
• Bray F , FerlayJ , SoerjomataramIet al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Anzai M , MorikawaM , OkunoTet al. Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer. Medicine96(51), 1–6 (2017).
   Web of Science ®Google Scholar
• Subramania J , GovindanR. Lung cancer in never smokers: a review. J. Clin. Oncol.25(5), 561–570 (2007).
   PubMed Web of Science ®Google Scholar
• Sun S , SchillerJH , GazdarAF. Lung cancer in never smokers – a different disease. Nat. Rev. Cancer7(10), 778–790 (2007).
   PubMed Web of Science ®Google Scholar
• Grillone K , RiilloC , SciontiFet al. Non-coding RNAs in cancer: platforms and strategies for investigating the genomic ‘dark matter’. J. Exp. Clin. Cancer Res.39(1), 1–19 (2020).
   PubMed Web of Science ®Google Scholar
• He D , WangJ , LuYet al. LncRNA functional networks in oligodendrocytes reveal stage-specific myelination control by an lncOL1/Suz12 complex in the CNS. Neuron93(2), 362–378 (2017).
   PubMed Web of Science ®Google Scholar
• Miao Y , AjamiNE , HuangT-Set al. Enhancer-associated long non-coding RNA LEENE regulates endothelial nitric oxide synthase and endothelial function. Nat. Commun.9(1), 292 (2018).
   PubMedGoogle Scholar
• Pavlaki I , AlammariF , SunBet al. The long non-coding RNA PAUPAR promotes KAP 1-dependent chromatin changes and regulates olfactory bulb neurogenesis. EMBO J.37(10), e98219 (2018).
   PubMed Web of Science ®Google Scholar
• Wang J-Z , XiangJJ , WuLGet al. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis. BMC Cancer17(1), 1–8 (2017).
   PubMedGoogle Scholar
• Zhang X , WangW , ZhuWet al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int. J. Mol. Sci.20(22), 5573 (2019).
   PubMed Web of Science ®Google Scholar
• Wang B-G , XuQ , LvZet al. Association of twelve polymorphisms in three onco-lncRNA genes with hepatocellular cancer risk and prognosis: a case-control study. World J. Gastroenterol.24(23), 2482 (2018).
   PubMed Web of Science ®Google Scholar
• Fang Y , FullwoodMJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics Proteomics Bioinformatics14(1), 42–54 (2016).
   PubMed Web of Science ®Google Scholar
• Hu Z , ChenJ , MengP , LiM. Association between NEAT1 polymorphism and the risk of lung cancer: a protocol for systematic review and meta-analysis. Medicine100(16), 1–4 (2021).
   Web of Science ®Google Scholar
• Jiang C , LiY , ZhaoZet al. Identifying and functionally characterizing tissue-specific and ubiquitously expressed human lncRNAs. Oncotarget7(6), 7120 (2016).
   PubMedGoogle Scholar
• Bi Y , CuiZ , LiHet al. Polymorphisms in long noncoding RNA-prostate cancer-associated transcript 1 are associated with lung cancer susceptibility in a northeastern Chinese population. DNA Cell Biol.38(11), 1357–1365 (2019).
   PubMed Web of Science ®Google Scholar
• Gao P , WeiGH. Genomic insight into the role of lncRNAs in cancer susceptibility. Int. J. Mol. Sci.18(6), 1239 (2017).
   PubMed Web of Science ®Google Scholar
• Abdi E , Latifi-NavidS. Long noncoding RNA polymorphisms and hepatocellular carcinoma and pancreatic cancer risk. Per. Med.20(2), 193–200 (2023).
   PubMed Web of Science ®Google Scholar
• Zhang Z , GuM , GuZ , LouYR. Role of long non-coding RNA polymorphisms in cancer chemotherapeutic response. J. Pers. Med.11(6), 513 (2021).
   PubMed Web of Science ®Google Scholar
• Chen B , DragomirMP , YangCet al. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct. Target. Ther.7(1), 121 (2022).
   PubMed Web of Science ®Google Scholar
• Chae Y , RohJ , KimW. The roles played by long non-coding RNAs in glioma resistance. Int. J. Mol. Sci.22(13), 6834 (2021).
   PubMed Web of Science ®Google Scholar
• Minotti L , AgnolettoC , BaldassariFet al. SNPs and somatic mutation on long non-coding RNA: new frontier in the cancer studies? High Throughput 7(4), 34 (2018).
   PubMedGoogle Scholar
• Abdi E , Latifi-NavidF , ZahriSet al. SNP–SNP interactions of oncogenic long non-coding RNAs HOTAIR and HOTTIP on gastric cancer susceptibility. Sci. Rep.10(1), 1–12 (2020).
   PubMed Web of Science ®Google Scholar
• Abdi E , Latifi-NavidS , Kholghi-OskooeiV , PourfarziF , YazdanbodA. Interaction between lncRNAs HOTAIR and MALAT1 tagSNPs in gastric cancer. Br. J. Biomed. Sci.78(3), 147–150 (2021).
   PubMed Web of Science ®Google Scholar
• Abdi E , Latifi-NavidS , Latifi-NavidH , SafaralizadehR. LncRNA polymorphisms and upper gastrointestinal cancer risk. Pathol. Res. Pract.218, 153324 (2021).
   PubMed Web of Science ®Google Scholar
• Abdi E , Latifi-NavidS , Latifi-NavidH. Long noncoding RNA polymorphisms and colorectal cancer risk: progression and future perspectives. Environ. Mol. Mutagen.63(2), 98–112 (2022).
   PubMed Web of Science ®Google Scholar
• Abdi E , Latifi-NavidS. LncRNA polymorphisms and urologic cancer risk. Environ. Mol. Mutagen.63(4), 190–203 (2022).
   PubMed Web of Science ®Google Scholar
• Abdi E , Latifi-NavidS , Latifi-NavidH. LncRNA polymorphisms and breast cancer risk. Pathol. Res. Pract.229, 153729 (2022).
   PubMed Web of Science ®Google Scholar
• Abdi E , Latifi-NavidS. Emerging long noncoding RNA polymorphisms as novel predictors of survival in cancer. Pathol. Res. Pract.239, 154165 (2022).
   PubMed Web of Science ®Google Scholar
• Yin Z , CuiZ , LiH , LiJ , ZhaoB. Polymorphisms in the H19 gene and the risk of lung cancer among female never smokers in Shenyang, China. BMC Cancer18(1), 1–8 (2018).
   PubMedGoogle Scholar
• Wang G , LiuQ , CuiK , MaA , ZhangH. Association between H19 polymorphisms and NSCLC risk in a Chinese population. J. BUON24, 913–917 (2019).
   PubMed Web of Science ®Google Scholar
• Chen M , CaiD , GuH , YangJ , FanL. MALAT1 rs619586 A/G polymorphisms are associated with decreased risk of lung cancer. Medicine100(12), e23716 (2021).
   PubMed Web of Science ®Google Scholar
• Wang C , LiY , LiYet al. HOTAIR lncRNA SNPs rs920778 and rs1899663 are associated with smoking, male gender, and squamous cell carcinoma in a Chinese lung cancer population. Acta Pharmacol. Sin.39(11), 1797–1803 (2018).
   PubMed Web of Science ®Google Scholar
• Li H , YangZ , LiJet al. Genetic variants in lncRNA HOTAIR are associated with lung cancer susceptibility in a Chinese Han population in China: a case–control study. Cancer Manag. Res.10, 5209 (2018).
   PubMed Web of Science ®Google Scholar
• Ren MM , XuS , WeiY-Bet al. Roles of HOTAIR in lung cancer susceptibility and prognosis. Mol. Genet. Genomic Med.8(7), e1299 (2020).
   PubMed Web of Science ®Google Scholar
• Wang S , CuiZ , LiHet al. LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese northeast Han population: a case–control study. Pathol. Res. Pract.215(12), 152723 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang Z , LiH , LiJet al. Polymorphisms in the PVT1 gene and susceptibility to the lung cancer in a Chinese northeast population: a case–control study. J. Cancer11(2), 468 (2020).
   PubMed Web of Science ®Google Scholar
• Yang Z , LiH , LiJet al. Association between long noncoding RNA MEG3 polymorphisms and lung cancer susceptibility in Chinese northeast population. DNA Cell Biol.37(10), 812–820 (2018).
   PubMed Web of Science ®Google Scholar
• Wang W , XiongW , ZhangJet al. The contribution of MALAT1 gene rs3200401 and MEG3 gene rs7158663 to the risk of lung, colorectal, gastric and liver cancer. Pathol. Res. Pract.240, 154212 (2022).
   PubMed Web of Science ®Google Scholar
• Lv X , CuiZ , LiHet al. Polymorphism in lncRNA AC008392.1 and its interaction with smoking on the risk of lung cancer in a Chinese population. Cancer Manag. Res.10, 1377 (2018).
   PubMed Web of Science ®Google Scholar
• Li J , LiH , LvXet al. Polymorphism in lncRNA AC016683.6 and its interaction with smoking exposure on the susceptibility of lung cancer. Cancer Cell Int.18(1), 1–9 (2018).
   PubMedGoogle Scholar
• Yu W-L , YaoJ-J , XieZ-Z , HuangY-J , XiaoS. LncRNA PRNCR1 rs1456315 and CCAT2 rs6983267 polymorphisms on 8q24 associated with lung cancer. Int. J. Gen. Med.14, 255 (2021).
   PubMed Web of Science ®Google Scholar
• Feng T , FengN , ZhuTet al. A SNP-mediated lncRNA (LOC146880) and microRNA (miR-539-5p) interaction and its potential impact on the NSCLC risk. J. Exp. Clin. Cancer Res.39(1), 1–12 (2020).
   PubMed Web of Science ®Google Scholar
• Brannan CI , DeesEC , IngramRS , TilghmanSM. The product of the H19 gene may function as an RNA. Mol. Cell. Biol.10(1), 28–36 (1990).
   PubMed Web of Science ®Google Scholar
• Tsang WP , NgAK , NgSSet al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis31(3), 350–358 (2010).
   PubMed Web of Science ®Google Scholar
• Wang Y-C , TsaoSM , LiYTet al. The relationship between long noncoding RNA H19 polymorphism and the epidermal growth factor receptor phenotypes on the clinicopathological characteristics of lung adenocarcinoma. Int. J. Environ. Res. Public Health18(6), 2862 (2021).
   PubMed Web of Science ®Google Scholar
• Xu C , YangM , TianJ , WangX , LiZ. MALAT-1: a long non-coding RNA and its important 3′end functional motif in colorectal cancer metastasis. Int. J. Oncol.39(1), 169–175 (2011).
   PubMed Web of Science ®Google Scholar
• Sun Z , OuC , LiuJet al. YAP1-induced MALAT1 promotes epithelial–mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene38(14), 2627–2644 (2019).
   PubMed Web of Science ®Google Scholar
• Gezer U , ÖzgürE , CetinkayaM , IsinM , DalayN. Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes. Cell Biol. Int.38(9), 1076–1079 (2014).
   PubMed Web of Science ®Google Scholar
• Ji P , DiederichsS , WangWet al. MALAT-1, a novel noncoding RNA, and thymosin β 4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene22(39), 8031–8041 (2003).
   PubMed Web of Science ®Google Scholar
• Gupta RA , ShahN , WangKCet al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature464(7291), 1071–1076 (2010).
   PubMed Web of Science ®Google Scholar
• Rinn JL , KerteszM , WangJKet al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell129(7), 1311–1323 (2007).
   PubMed Web of Science ®Google Scholar
• Geng Y , XieSL , LiQ , MaJ , WangGY. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J. Int. Med. Res.39(6), 2119–2128 (2011).
   PubMed Web of Science ®Google Scholar
• Dadaş E , AydınM. Effect of HOTAIR rs12826786 and rs1899663 polymorphisms on lung cancer susceptibility and clinicopathological characteristics in a Turkish population: a hospital-based case–control study. Cell. Mol. Biol.64(7), 97–102 (2018).
   PubMed Web of Science ®Google Scholar
• Prensner JR , IyerMK , BalbinOAet al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol.29(8), 742–749 (2011).
   PubMed Web of Science ®Google Scholar
• Wu Y , YangL , ZhaoJet al. Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer. Mol. Cancer14(1), 1–12 (2015).
   PubMedGoogle Scholar
• Ding X , ZhangY , YangHet al. Long non-coding RNAs may serve as biomarkers in breast cancer combined with primary lung cancer. Oncotarget8(35), 58210 (2017).
   PubMedGoogle Scholar
• Fang J , LiY , ZhangJet al. Correlation between polymorphisms in microRNA-regulated genes and cervical cancer susceptibility in a Xinjiang Uygur population. Oncotarget8(19), 31758 (2017).
   PubMedGoogle Scholar
• Hu Y-W , GuoF-X , XuY-Jet al. Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN. J. Clin. Invest.129(3), 1115–1128 (2019).
   PubMed Web of Science ®Google Scholar
• Yuan H , LiuH , LiuZet al. A novel genetic variant in long non-coding RNA gene NEXN-AS1 is associated with risk of lung cancer. Sci. Rep.6(1), 1–8 (2016).
   PubMed Web of Science ®Google Scholar
• Beck-Engeser GB , LumAM , HuppiKet al. Pvt1-encoded microRNAs in oncogenesis. Retrovirology5(1), 1–14 (2008).
   PubMedGoogle Scholar
• Tseng Y-Y , MoriarityBS , GongWet al. PVT1 dependence in cancer with MYC copy-number increase. Nature512(7512), 82–86 (2014).
   PubMed Web of Science ®Google Scholar
• Carramusa L , ContinoF , FerroAet al. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J. Cell. Physiol.213(2), 511–518 (2007).
   PubMed Web of Science ®Google Scholar
• Yin J , WenJ , HangDet al. Expression quantitative trait loci for CARD8 contributes to risk of two infection-related cancers – hepatocellular carcinoma and cervical cancer. PLOS ONE10(7), e0132352 (2015).
   PubMed Web of Science ®Google Scholar
• Han J , ZhouW , JiaMet al. Expression quantitative trait loci in long non-coding RNA PAX8-AS1 are associated with decreased risk of cervical cancer. Mol. Genet. Genomics291(4), 1743–1748 (2016).
   PubMed Web of Science ®Google Scholar
• Ma S , YangJ , SongCet al. Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma. PLOS ONE12(3), e0173700 (2017).
   PubMed Web of Science ®Google Scholar
• Kasagi Y , OkiE , AndoKet al. The expression of CCAT2, a novel long noncoding RNA transcript, and rs6983267 single-nucleotide polymorphism genotypes in colorectal cancers. Oncology92(1), 48–54 (2017).
   PubMed Web of Science ®Google Scholar
• Pestell RG , YuZ. Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo. Asian J. Androl.16(2), 268 (2014).
   PubMed Web of Science ®Google Scholar
• Guo R , HuT , LiuYet al. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis. Biosci. Rep.40(7), BSR20193153 (2020).
   PubMedGoogle Scholar
• Qiu M , XuY , YangXet al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol.35(6), 5375–5380 (2014).
   PubMedGoogle Scholar
• Feng N , ChingT , WangYet al. Analysis of microarray data on gene expression and methylation to identify long non-coding RNAs in non-small cell lung cancer. Sci. Rep.6(1), 1–11 (2016).
   PubMedGoogle Scholar
• Daniyal A , SantosoI , GunawanNHet al. Genetic influences in breast cancer drug resistance. Breast Cancer (Dove Med. Press)13, 59–85 (2021).
   PubMed Web of Science ®Google Scholar
• Loewen G , JayawickramarajahJ , ZhuoY , ShanB. Functions of lncRNA HOTAIR in lung cancer. J. Hematol. Oncology7(1), 1–10 (2014).
   PubMedGoogle Scholar
• Ge X , LiG-Y , JiangLet al. Long noncoding RNA CAR10 promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis. Oncogene38(16), 3061–3076 (2019).
   PubMed Web of Science ®Google Scholar
• Sun R , WangR , ChangSet al. Long non-coding RNA in drug resistance of non-small cell lung cancer: a mini review. Front. Pharmacol.10, 1457 (2019).
   PubMed Web of Science ®Google Scholar
• Ye P , FengL , ShiS , DongC. The mechanisms of lncRNA-mediated multidrug resistance and the clinical application prospects of lncRNAs in breast cancer. Cancers14(9), 2101 (2022).
   PubMed Web of Science ®Google Scholar
• Wang L , MaL , XuFet al. Role of long non-coding RNA in drug resistance in non-small cell lung cancer. Thorac. Cancer9(7), 761–768 (2018).
   PubMed Web of Science ®Google Scholar
• Ge P , CaoL , YaoY-Jet al. LncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR185-5p–SIX1 axis. Onco Targets Ther.12, 6105 (2019).
   PubMed Web of Science ®Google Scholar
• Hu L , ChenS-H , LvQ-Let al. Clinical significance of long non-coding RNA CASC8 rs10505477 polymorphism in lung cancer susceptibility, platinum-based chemotherapy response, and toxicity. Int. J. Environ. Res. Public Health13(6), 545 (2016).
   PubMed Web of Science ®Google Scholar
• Gong W-J , PengJ-B , YinJ-Yet al. Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer. Acta Pharmacol. Sin.38(4), 581–590 (2017).
   PubMed Web of Science ®Google Scholar
• Gong W-J , YinJ-Y , LiX-Pet al. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Tumour Biol.37(6), 8349–8358 (2016).
   PubMedGoogle Scholar
• Chang A . Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer71(1), 3–10 (2011).
   PubMed Web of Science ®Google Scholar